DNA Ploidy Analysis in Acute Leukemia by Flow Cytometry
DOI:
https://doi.org/10.21276/apalm.3382Keywords:
Acute Leukemia, DNA ploidy, FlowcytometryAbstract
Background: The detection of chromosomal abnormalities holds significant diagnostic and prognostic value in acute leukemia. While cytogenetics is the standard technique for evaluating ploidy, it is a tedious and labor-intensive process compared to flow cytometry. Flow cytometric determination of leukemic cell DNA content reflects the proliferative index of blast cells. This technique is rapid, cost-effective, sensitive, easy to perform, independent of the tumor's proliferation state, and applicable to nearly all hematological malignancies.
Materials and Methods: This study was conducted to determine DNA ploidy in all acute leukemia cases using flow cytometry over a one-year period. A total of 53 new acute leukemia cases were diagnosed based on morphology, special stains, and immunophenotyping. The DNA index was then correlated with other clinico-hematological parameters.
Results: In our study, the overall incidence of aneuploidy was 32.07%, with 24% being hyperdiploid and 8% hypoploid. The majority of the aneuploid cases were male (58.8%), while diploid cases showed a female preponderance. We observed that acute lymphoblastic leukemia (ALL) patients with hyperdiploidy demonstrated favorable prognostic factors (i.e., clinico-hematological parameters), whereas hypoploidy was associated with poorer prognostic factors. In acute myeloid leukemia (AML) patients, hyperdiploidy was linked to poor prognostic factors.
Conclusion: We recommend that each newly diagnosed case be analyzed by flow cytometry, in addition to karyotyping, for early identification of patients who may benefit from conventional induction therapy.
References
1. Dey P. Aneuploidy and malignancy: an unsolved equation. J Clin Pathol. 2004;57(12):1245-9.
2. Darzynkiewicz Z, Huang X, Zhao H. Analysis of cellular DNA content by flow cytometry. Curr Protoc Immunol. 2017;119(1):5-7.
3. Kumar B, Bhatia P, Trehan A, Singh A, Kaul D, Bansal D. DNA ploidy and S phase fraction analysis in paediatric B cell acute lymphoblastic leukemia cases: a tertiary care centre experience. Asian Pac J Cancer Prev. 2015;16(17):7917-22.
4. Tembhare P, Badrinath Y, Ghogale S, Patkar N, Dhole N, Dalavi P, et al. A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping. Cytometry A. 2016;89(3):281-91.
5. National Accreditation Board for Hospitals and healthcare providers. Biomedical waste management rules 2016 [Internet]. New Delhi: Gazette of India, Extraordinary, Part II, Section 3, Subsection (1); 2016 Mar 28 [updated 2016 Aug 03; cited 2016 Aug 20]. Available from: http://nabh.co/announcement/bmw_rules_2016.pdf
6. Hiddemann W, Wörmann B, Ritter J, Thiel E, Göhde W, Lahme B, et al. Frequency and clinical significance of DNA aneuploidy in acute leukemia. Ann N Y Acad Sci. 1986;468(1):227-40.
7. Barlogie B, Stass S, Dixon D, Keating M, Cork A, Trujillo JM, et al. DNA aneuploidy in adult acute leukemia. Cancer Genet Cytogenet. 1987;28(2):213-28.
8. Andreeff M, Assing G, Cirrincione C. Prognostic value of DNA/RNA flow cytometry in myeloblastic and lymphoblastic leukemia in adults: RNA content and S-phase predict remission duration and survival in multivariate analysis. Ann N Y Acad Sci. 1986;468(1):387-406.
9. Sousa D, Ferreira F, Felix F, Lopes M. Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival. Rev Bras Hematol Hemoter. 2015;37(4):223-9.
10. Taleb F, Wahid M, Azeez H, Zidan A, Esh S. Flow cytometric analysis of nuclear DNA ploidy and proliferative activity in acute lymphoblastic leukemia. J Egypt Natl Canc Inst. 2002;14(4):303-10.
11. Almozain N, Mashi A, Al-Sweedan S, Belgaumi A, Rawas F, Alnounou R. Discrepancies between DNA index by flow cytometry and cytogenetic studies in childhood B-lymphoblastic leukemia. J Appl Hematol. 2018;9:45-50.
12. Shahidi M, Rakshan M, Farhadi M. Is DNA index measurement a helpful tool to evaluate Iranian children with acute lymphoblastic leukemia (ALL)? Int J Hematol Therap. 2016;2(1):1-4.
13. Khalifa AS, El-Kardani TA, Fayek MH, Abd-El Ghaffar AA, Sabry FH, et al. Flowcytometric study childhood acute leukemia immunophenotyping and DNA analysis. Egypt J Haematol. 1997;22(1-2):1-23.
14. Rachieru-Sourisseau P, Baranger L, Dastugue N, Robert A, Geneviève F, Kuhlein E, et al. DNA index in childhood acute lymphoblastic leukaemia: a karyotypic method to validate the flow cytometric measurement. Int J Lab Hematol. 2010;32(3):288-98.
15. Pui CH, Williams DL, Roberson PK, Raimondi SC, Behm FG, Lewis SH, et al. Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. J Clin Oncol. 1988;6(1):56-61.
16. Basu O, Streffer C, Zolzer F. DNA ploidy: a prognostic factor of acute lymphoblastic leukemia in childhood. Asian J Exp Sci. 2009;23(1):33-8.
17. Hiddemann W, Wörmann B, Göhde W, Büchner T. DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypes. Cancer. 1986;57(11):2146-52.
18. Ameen NA, Faraj SA, Ghali HH. DNA quantitation in pediatric acute leukemia. Karbala J Med. 2015;8(2):2229-34.
19. Vidriales MB, Berges MC, Orfeo A, Gonazalez M, Lopez A, Canizo MC, et al. DNA aneuploidy in acute myeloblastic leukemia is associated with a high expression of lymphoid markers. Cytometry. 1995;22:22-5.
20. Jahic A, Iljazovic E, Hasic S, Arnautovic AC, Sabitovic D, Mesanovic S, et al. Prognostic parameters of acute myeloid leukaemia at presentation. Med Arch. 2017;71(1):20-4.
21. Sandahl JD, Kjeldsen E, Abrahamsson J, Ha SY, Heldrup J, Jahnukainen K, et al. Ploidy and clinical characteristics of childhood acute myeloid leukemia: a NOPHO-AML study. Genes Chromosomes Cancer. 2014;53(8):667-75.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Monika Gupta, Shivani Singhal, Sujata Kumari SP Prasad, Sunita Singh
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
